Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$191.17 - $325.63 $208,184 - $354,611
-1,089 Reduced 37.26%
1,834 $597,000
Q4 2023

Jun 03, 2024

SELL
$160.99 - $215.69 $90,959 - $121,864
-565 Reduced 16.2%
2,923 $557,000
Q4 2023

Jan 29, 2024

SELL
$160.99 - $215.69 $90,959 - $121,864
-565 Reduced 16.2%
2,923 $557,000
Q3 2023

Jun 03, 2024

BUY
$194.33 - $283.97 $270,118 - $394,718
1,390 Added 66.25%
3,488 $694,000
Q3 2023

Oct 10, 2023

BUY
$194.33 - $283.97 $270,118 - $394,718
1,390 Added 66.25%
3,488 $694,000
Q2 2023

Jun 03, 2024

SELL
$223.05 - $302.68 $1.39 Million - $1.88 Million
-6,226 Reduced 74.8%
2,098 $598,000
Q2 2023

Jul 24, 2023

SELL
$223.05 - $302.68 $1.39 Million - $1.88 Million
-6,226 Reduced 74.8%
2,098 $598,000
Q1 2023

Jun 03, 2024

BUY
$175.41 - $217.92 $1.14 Million - $1.41 Million
6,490 Added 353.87%
8,324 $1.8 Million
Q1 2023

Apr 12, 2023

BUY
$175.41 - $217.92 $131,732 - $163,657
751 Added 9.92%
8,324 $1.8 Million
Q4 2022

Feb 14, 2023

SELL
$204.38 - $296.82 $14,306 - $20,777
-70 Reduced 0.92%
7,573 $1.56 Million
Q3 2022

Nov 04, 2022

BUY
$195.21 - $310.53 $410,136 - $652,423
2,101 Added 37.91%
7,643 $2.13 Million
Q2 2022

Jul 27, 2022

BUY
$115.91 - $214.48 $415,073 - $768,052
3,581 Added 182.61%
5,542 $1.06 Million
Q1 2022

May 13, 2022

BUY
$127.96 - $207.36 $250,929 - $406,632
1,961 New
1,961 $407,000
Q2 2021

Aug 06, 2021

SELL
$131.45 - $201.49 $444,826 - $681,842
-3,384 Closed
0 $0
Q1 2021

May 11, 2021

BUY
$92.73 - $142.05 $313,798 - $480,697
3,384 New
3,384 $441,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.